...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Notice anything different about #11

All this is another marketing announcement to mollify the lack of AGM creds!

Share
New Message
Please login to post a reply